FORCE advocates for families facing hereditary breast and ovarian cancer in areas such as access to care, research funding, insurance, and privacy.
In May 2012, The United States Preventive Services Task Force (USPSTF) issued their recommended changes for prostate cancer screening in men. The draft guidelines recommended against PSA screening for men of any age. In response to the concerns submitted by FORCE that the guidelines might not apply to people with BRCA mutations, the USPSTF modified the guidelines to reflect this important detail. Read the full USPSTF Guidelines for Screening for Prostate Cancer.
FORCE contacted the USPSTF in response to the draft guideline changes and presented the following information:
Men with BRCA 2 mutations face:
The USPSTF issued new prostate cancer screening guidelines on May 21, 2012.
The Task Force took our concerns about prostate cancer in men with BRCA mutations into account and added the following statement to their guidelines:
"This recommendation...does not consider PSA-based testing in men with known BRCA gene mutations who may be at increased risk for prostate cancer."